Webinar: The Emerging Role of Biomarkers in mRCC: Selecting Patients and Predicting Response to Treatment

October 23, 2020

Guided by a comprehensive analysis of the current educational gaps in optimal care, this program will translate findings in science and clinical research to improve knowledge, competence, and confidence of healthcare professionals in managing patients with metastatic renal cell carcinoma (mRCC).

The agenda for this program is as follows:
  • The Breadth of Biomarker Studies in mRCC: Surveillance and Drivers of Treatment Response – David Braun, MD, PhD
  • Predicting Responses to Immune Checkpoint Inhibition in Solid Tumors: Genomic Alterations and Immune Cell Infiltration in Advanced Clear Cell RCC – Brian Shuch, MD
  • Putting it All Together: Future Role of Biomarkers in Predicting mRCC Treatment Response – Hans Hammers, MD, MPH

Developed in partnership with KidneyCan

Supported by educational grants from Bristol Myers Squibb, Exelixis, and Merck & Co.

Please login or create an account to complete your evaluation and download your certificate. 

Target Audience

  • Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Nurses

Learning Objectives

Upon completion of this activity you will be better able to:

  • Discuss the current studies on biomarkers in metastatic renal cell carcinoma (mRCC), citing lessons learned from other solid tumor types
  • Identify current guidelines for management of stages I-III RCC, as compared with stage IV (mRCC)
  • Describe how the current and emerging predictive ability of different biomarkers can inform treatment decision-making in mRCC
Course summary
Available credit: 
  • 1.50 AANP Contact Hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Category I Credit for Physician Assistants
  • 1.50 ANCC Nurse Contact Hours
  • 1.50 Attendance
Course opens: 
10/21/2020
Course expires: 
01/23/2021
Event starts: 
10/23/2020 - 12:00pm
Event ends: 
10/23/2020 - 1:30pm
Cost:
$0.00
Rating: 
0
Faculty Disclosures:

David Braun, MD, PhD
Dana-Farber Cancer Institute
Boston, MA
Disclosure: Has no financial relationships with commercial interest(s).

Hans Hammers, MD, PhD
UT Southwestern Simmons Comprehensive Cancer Center
Dallas, TX
Disclosure: Consultant/Advisory Board: Pfizer, Merck, Bristol-Myers-Squibb, Eli Lilly, Corvus, Surface Oncoloy, Exelixis, Novartis, Armo Biosciences

Brian Shuch, MD
UCLA
Los Angeles, CA
Disclosure: Has no financial relationships with commercial interest(s).

Planner Disclosures:

Jessica Joseph, MBA
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s). 

Bryan Lewis, JD
KidneyCan
Philadelphia, PA
Disclosure: Has no financial relationships with commercial interest(s).

Susan Poteat, MS
KidneyCan
Beavercreek, OH
Disclosure: Has no financial relationships with commercial interest(s).

Reviewer Disclosures:

Joy Lee, PharmD
Electronic Medical Record Manager 
Office of Jung Lack Lee, MD
Flushing, NY
Disclosure: Has no financial relationships with commercial interest(s).

Blaithin McMahon, MD, Ph.D
Assistant Professor 
Medical University of South Carolina
Charleston, South Carolina
Disclosure: Has no financial relationships with commercial interest(s).

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician

The National Kidney Foundation designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner, Nurse

Awarded 1.5 contact hours of continuing nursing education.

Physician Assistant 

National Kidney Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 1.50 AANP Contact Hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Category I Credit for Physician Assistants
  • 1.50 ANCC Nurse Contact Hours
  • 1.50 Attendance

Price

Cost:
$0.00
Please login or register for a PERC account to take this course.